Salarius Pharmaceuticals Inc (SLRX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
David J. Arthur
Employees:
30
2450 Holcombe Boulevard Suite J-608 Houston, TX 77021
346 772 0346

Salarius Pharmaceuticals, Inc. a clinical-stage biotechnology company, develops epigenetic-based cancer treatments.

Data derived from most recent annual or quarterly report
Market Cap 18.806 Million Shares Outstanding45.206 Million Avg 30-day Volume 408.175 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue0.0 Debt to Equity0.0 EBITDA0
Price to Book Value0.0 Operating Margin0.0 Enterprise Value13.797 Million
Current Ratio21.822 EPS Growth0 Quick Ratio21.082
1 Yr BETA 1.7863 52-week High/Low 3.5 / 0.39 Profit Margin0.0
Operating Cash Flow Growth0.0 Altman Z-Score0.0 Free Cash Flow to Firm 0
View SEC Filings from SLRX instead.

View recent insider trading info

Funds Holding SLRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SLRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HANISH ARNOLD C

  • Director
30,000 2022-01-20 2

ROSENBLUM MARK J EXEC VP FINANCE, CFO

  • Officer
200,000 2022-01-20 3

LIEBER JONATHAN I

  • Director
30,000 2022-01-20 1

LAMMERS PAUL

  • Director
30,000 2022-01-20 1

MCVICAR WILLIAM K.

  • Director
30,000 2022-01-20 1

ARTHUR DAVID J. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
500,000 2022-01-20 4

BURLESON TESS

  • Director
30,000 2022-01-20 1

MCCREEDY BRUCE J JR.

  • Director
30,000 2022-01-20 1

NORTHRUP JONATHAN P

  • Director
0 2020-03-23 0

JORDAN SCOTT CHIEF BUSINESS OFFICER

  • Officer
31,609 2020-02-18 0

CHUANG PAO-YU CONTROLLER

  • Officer
0 2019-09-10 0

BOSTON FOUNDATION, INC.

  • 10% Owner
No longer subject to file 2019-01-09 0

WESTPHAL CHRISTOPH H

  • 10% Owner
3,941,118 2018-10-16 0

LONGWOOD FUND II, L.P.

  • 10% Owner
No longer subject to file 2018-10-16 0

HUTT PETER BARTON

  • Director
0 2018-07-25 0

KOZIN MARC D

  • Director
0 2018-07-25 0

RANDLE STUART A

  • Director
0 2018-07-25 0

STACY MICHELLE

  • Director
0 2018-07-25 0

TUNG ROGER D

  • Director
0 2018-07-25 0

MCCABE JOHN P. CHIEF FINANCIAL OFFICER

  • Officer
0 2018-06-14 0

WESSEL THOMAS CHIEF MEDICAL OFFICER

  • Officer
0 2018-01-17 0

WOO ELIZABETH SVP, INVESTOR RELATIONS

  • Officer
0 2018-01-17 0

CAPELLO JEFFREY D

  • Director
0 2017-07-26 0

PEREZ ROBERT J

  • Director
0 2017-07-26 0

MACKINNON RODERICK

  • Director
0 2017-07-26 0

HADFIELD ROBERT GENERAL COUNSEL & SECRETARY

  • Officer
0 2017-01-18 0

LINDEMANN KATHARINE CHIEF OPERATING OFFICER

  • Officer
0 2017-01-18 0

SCULLEY JOHN

  • Director
0 2016-06-08 0

HAHN MARINA PRESIDENT, CONSUMER

  • Officer
0 2015-11-11 0

CERMAK JENNIFER VP PROGRAM MANAGEMENT

  • Officer
0 2015-01-28 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

LAMMERS PAUL - Director

2022-01-21 16:05:04 -0500 2022-01-20 A 30,000 a 30,000 direct

LIEBER JONATHAN I - Director

2022-01-21 16:10:03 -0500 2022-01-20 A 30,000 a 30,000 direct

HANISH ARNOLD C - Director

2022-01-21 16:06:07 -0500 2022-01-20 A 30,000 a 30,000 direct

BURLESON TESS - Director

2022-01-21 16:07:01 -0500 2022-01-20 A 30,000 a 30,000 direct

ARTHUR DAVID J. - Director - Officer CHIEF EXECUTIVE OFFICER

2022-01-21 16:08:11 -0500 2022-01-20 A 500,000 a 500,000 direct

ROSENBLUM MARK J - Officer EXEC VP FINANCE, CFO

2022-01-21 16:03:37 -0500 2022-01-20 A 200,000 a 200,000 direct

MCVICAR WILLIAM K. - Director

2022-01-21 16:09:04 -0500 2022-01-20 A 30,000 a 30,000 direct

MCCREEDY BRUCE J JR. - Director

2022-01-21 16:11:51 -0500 2022-01-20 A 30,000 a 30,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SALARIUS PHARMACEUTICALS INC SLRX 2022-01-28 16:15:03 UTC -3.6691 3.7391 600000
SALARIUS PHARMACEUTICALS INC SLRX 2022-01-28 15:45:04 UTC -3.6691 3.7391 600000
SALARIUS PHARMACEUTICALS INC SLRX 2022-01-28 15:15:03 UTC -3.6691 3.7391 600000
SALARIUS PHARMACEUTICALS INC SLRX 2022-01-28 14:45:03 UTC -3.9232 3.9932 600000
SALARIUS PHARMACEUTICALS INC SLRX 2022-01-28 14:15:03 UTC -3.9232 3.9932 600000
SALARIUS PHARMACEUTICALS INC SLRX 2022-01-28 13:45:03 UTC -3.9232 3.9932 600000
SALARIUS PHARMACEUTICALS INC SLRX 2022-01-28 13:15:03 UTC -3.9232 3.9932 600000
SALARIUS PHARMACEUTICALS INC SLRX 2022-01-28 12:45:03 UTC -3.9232 3.9932 600000
SALARIUS PHARMACEUTICALS INC SLRX 2022-01-27 22:15:03 UTC -3.9232 3.9932 550000
SALARIUS PHARMACEUTICALS INC SLRX 2022-01-27 21:45:03 UTC -3.9232 3.9932 550000
SALARIUS PHARMACEUTICALS INC SLRX 2022-01-27 21:15:03 UTC -3.9232 3.9932 550000
SALARIUS PHARMACEUTICALS INC SLRX 2022-01-27 20:45:03 UTC -3.5199 3.5899 550000
SALARIUS PHARMACEUTICALS INC SLRX 2022-01-27 20:15:04 UTC -3.5199 3.5899 550000
SALARIUS PHARMACEUTICALS INC SLRX 2022-01-27 19:45:03 UTC -3.5199 3.5899 550000
SALARIUS PHARMACEUTICALS INC SLRX 2022-01-27 19:15:03 UTC -3.5199 3.5899 550000
SALARIUS PHARMACEUTICALS INC SLRX 2022-01-27 18:45:03 UTC -3.5199 3.5899 550000
SALARIUS PHARMACEUTICALS INC SLRX 2022-01-27 18:15:03 UTC -3.5199 3.5899 550000
SALARIUS PHARMACEUTICALS INC SLRX 2022-01-27 17:45:03 UTC -3.5199 3.5899 550000
SALARIUS PHARMACEUTICALS INC SLRX 2022-01-27 17:15:03 UTC -3.5199 3.5899 550000
SALARIUS PHARMACEUTICALS INC SLRX 2022-01-27 16:45:03 UTC -3.5199 3.5899 550000

Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin

Short Position History (International Only)

Holder Net Short Position Position Date Origin
Squarepoint Ops LLC Salarius Pharmaceuticals Inc 0.54% 2019-10-09 UK
Squarepoint Ops LLC Salarius Pharmaceuticals Inc 0.61% 2019-10-10 UK
Squarepoint Ops LLC Salarius Pharmaceuticals Inc 0.7% 2019-01-01 GERMANY
Squarepoint Ops LLC Salarius Pharmaceuticals Inc 0.64% 2019-11-13 GERMANY

Elevate your investments